A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on
the percent change in fasting triglycerides (TG) from baseline.